Neuroscience Biomarkers and Biosignatures: Converging Technologies, Emerging Partnerships: Workshop Summary

Print

Cover Image

PAPERBACK
$32.50

Download

Table of Contents
Front Matter R1-R12
Summary 1-8
Introduction 9-14
1 Biomarker and Biosignature Principles 15-26
2 Potential Tools for Biomarker and Biosignature Development 27-38
3 Psychiatric and Drug Addiction Disorders 39-54
4 Neurological and Eye Diseases 55-70
A References 71-80
B Public Workshop on Neuroscience Biomarkers and Biosignatures: Converging Technologies, Emerging Partnerships 81-86
C Workshop Attendees 87-90
D Biographical Sketches of Invited Speakers, Committee Members, and Staff 91-116

View/Hide Left Panel

4:55 p.m.

General Discussion

Which biomarkers have the greatest potential for near-term impact on the development of treatments or key diagnostics for nervous system diseases?
What partnerships are needed to move forward?

DENNIS CHOI, Workshop Chair

Professor of Pharmacology & Experimental Therapeutics

Boston University

5:30 p.m.

ADJOURN

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement